The combination of diabetes and assignment to HT in the CEE-alone trial appeared to increase women’s risk for cognitive impairment beyond what might be predicted from their separate effects (although interaction P values were only of marginal significance).
← all excerpts
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.
1
—
—